《Table 5.IVIG dose and the total types of adverse reactions and intervention during the events.》

《Table 5.IVIG dose and the total types of adverse reactions and intervention during the events.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《静脉注射人免疫球蛋白临床应用的不良反应之三年回顾性研究（英文）》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

From 2015 to 2017，the highest incidence of adverse reactions was found in 2016（1.39%，Table 2）.Since the hospital changed the brand of IVIG，the number of people who had the adverse event was sharply reduced（0.13%，Table 2）.

图表编号XD0045067500    严禁用于非法目的
绘制时间2019.01.01
作者邵淑容、郭卫
绘制单位宁波市妇女儿童医院药剂科、温州医科大学附属眼视光医院神经分子神经药理学研究组、省部共建眼视光学和视觉科学国家重点实验室
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2 Recovery results of the total quantities of mould and yeast》2018.02.01
  2. 《Table 1 Condition survey of the model reaction of 1a and 2aa》2020.01.01
  3. 《Table 6 Adverse events and infections in the study cohort listed according to the time of their occurrence》2019.08.21
  4. 《Table 2 Details of the foils and their measured reaction rate and activity》2019.08.01
  5. 《Table 2 Comparison of the total import and export volume of fourprovinces and cities during 2014-2018》2019.07.01
  6. 《表7 不同年龄段与不良反应类型的卡方检验Tab 7 Chi-square test of different age groups and adverse reactions types》2019.01.20
  7. 《表5 民族与不良反应类型的卡方检验Tab 5 Chi-square test of ethnic groups and adverse reaction types》2019.01.20
  8. 《表6 性别与不良反应类型的卡方检验Tab 6 Chi-square test of gender and adverse reaction types》2019.01.20
  9. 《Table 1.Demographic data of patients with the adverse reactions.》2019.01.01
  10. 《Table 2.Total number of patients administrated of IVIG and the incidence of adverse reactions for 3 consecutive years.》2019.01.01
  11. 《表4 患者病史及不良反应史Tab.4 Medical history and adverse reactions history of patients》2019.02.15
  12. 《Table 1.Coverage of 2015 and 2016 publications by domain, total all publication types, Scopus and Web of Science.》
  13. 《表2 插管情况及不良反应的比较[n (%) ]Tab 2 Comparison of intubation and adverse reactions[n (%) ]》2019.01.20
  14. 《Table 2–The performance of various coagulants and their combinations (optimal dose and corresponding residual turbidity)》2019.07.15
  15. 《Table 2 The levels of total Gh, AGh and AGh/total Gh ratio in the groups》2018.05.18
  16. 《Table 4The incidence of adverse drug reactions between the two groups.》2018.12.15
  17. 《Table 2Types and doses of probiotics among the 14 studies.》2018.02.01
  18. 《表3 研究组与对照组不良反应发生情况对比 (n) Table 3 Comparison of adverse reactions between the study group and the control group (n)》2018.01.25
  19. 《表2 两组疗效及不良反应比较 (n) Table 2 Comparison of efficacy and adverse reactions between the two groups (n)》2018.01.25
  20. 《表2 不同反应温度对应的级数和速率常数Table 2 Relationship between reaction temperature and the order of reaction, and reaction velocity co》2018.05.20

随机翻阅

《表1 1952年有关建筑工程（学）系教师并入华南工学院数》 《表1促使学生学习的方式选项结果》 《表3 检验学习导向与数字化转型实践采用之间的关系（N=260)》 《表2 协整检验结果(Trace)》 《表1 辐照前后含菌量测定结果》 《表1 例1试题中的相关生物学学科核心素养表现》 《表1 酸奶预拌粉正交试验因素及水平》 《表2 100例糖尿病合并牙周病患者血糖水平[ () , mmol/L]》 《表5 不同处理对水分利用效率的影响》 《表3 实验组与对照组自我效能感描述性分析》